Welcome Mr. Vincent Chiu, Vice President and Director of Level Biotechnology, to visit Daniel Brothers Commercial & Law Firm.

Level Biotechnology is a globally renowned CRO service provider specializing in preclinical trials. Its preclinical testing center, covering nearly 2,500 square meters, boasts internationally recognized animal testing facilities, including an AAALAC-certified SPF (Specific Pathogen-Free) animal room and GLP (Good Laboratory Practice) testing capabilities that comply with global standards such as WHO, OECD, TAF, and FDA. This quality and scale have made Level Biotechnology a leader in Taiwan’s preclinical testing market, providing key services to the biotech industry, including safety assessment, toxicology testing, biocompatibility testing, and health food and cosmetic safety testing.

During this exchange, Vice President Vincent Chiu shared his years of practical experience in animal study design, GLP compliance management, and collaboration with multidisciplinary clients. He also provided an in-depth analysis of the current trends and challenges in preclinical testing for new drugs. He specifically shared how, through rigorous trial processes and adaptability, we help clients minimize resources, maximize benefits, shorten development timelines, and increase success rates.

This meeting not only deepened our understanding of Taiwan’s preclinical trial standards and market trends, but also strengthened the platform’s strategic positioning in helping clients identify high-quality CRO partnerships and accelerate biotech R&D processes.